Columbus, GA – RSV and Shingles Research Study

Respiratory Syncytial Virus (RSV) is a common virus that can cause respiratory infections, especially in infants and young children. RSV is highly contagious and spreads easily through respiratory secretions like saliva and mucus. Symptoms of an RSV infection can include coughing, wheezing, and fever, and in severe cases, it can cause pneumonia or bronchitis. In most cases, RSV infections are mild and go away on their own within a week or two without any treatment. However, in some cases, RSV infections can be serious and require hospitalization. There is no cure for RSV, but there are medications and treatments that can help manage symptoms and prevent complications in people at high risk, such as premature infants or those with weakened immune systems.

Shingles, caused by the varicella-zoster virus (the same virus that causes chickenpox), is a painful rash. The virus remains dormant after a person recovers from chickenpox, but it can reactivate after many years and cause shingles. The virus travels along nerve pathways to the skin, resulting in the characteristic rash.

Centricity Research is currently enrolling participants in an RSV and Shingles vaccine study at our Columbus, Georgia location. Compensation may be available for time and travel for qualified participants.  

You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number 219331.